Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,889 | $12,798 | $21,021 | $79,800 |
| - Cash | $406 | $14,786 | $51,189 | $91,349 |
| + Debt | $2,900 | $209 | $54 | $317 |
| Enterprise Value | $5,383 | -$1,779 | -$30,114 | -$11,232 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14,884 | -$49,258 | -$44,996 | -$32,627 |
| % Margin | – | – | – | – |
| Net Income | -$13,192 | -$48,926 | -$42,200 | -$32,722 |
| % Margin | – | – | – | – |
| EPS Diluted | -107.348 | -616.072 | -594.75 | -465.52 |
| % Growth | 82.6% | -3.6% | -27.8% | – |
| Operating Cash Flow | -$18,216 | -$40,889 | -$34,961 | -$31,224 |
| Capital Expenditures | $0 | -$14 | -$16 | -$130 |
| Free Cash Flow | -$18,216 | -$40,903 | -$34,978 | -$31,355 |